Lupus & antiphospholipid syndrome

High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosus

Lupus Sci MedPublished Mechanistic study

Authors' conclusion

The study suggests an association between BEL treatment and variations in T cells, particularly Tregs, in SLE pathologies involving various immune cells.

Study context

Population
Patients with SLE; peripheral blood T cells (CD3+)
Participants
22 vs 20
Comparison
Belimumab (BEL)-treated SLE vs non-BEL-treated SLE
  • BELn = 22
  • Non-BELn = 20reference
Outcome
T-cell clusters (TCLs, % of CD3+) significantly associated with BEL treatment (BEL-TCL)
Methodological detailsmass cytometry (25 marker panels), unsupervised machine-learning clustering (FlowSOM), linear mixed-effects model, time-series data
  • Mass cytometry (25 marker panels)
  • Unsupervised machine-learning clustering (FlowSOM)
  • Linear mixed-effects model
  • Time-series data

Main finding

As reported in the abstract

BEL-associated T-cell clusters (five BEL-TCLs: TCL 04, 07, 11, 12 and 27)

Increased proportion of Treg-like cluster TCL11 with BEL

coef=0.404

p=0.037

TCL27 increased, inversely correlating with baseline C3 levels

coef=0.222

p=0.037

Further findings

Clinical outcomes

Decrease in daily prednisolone use
coef=−0.1769, p=0.00074
Increase in serum CH50
coef=0.4653, p=0.003
Increase in serum C3
coef=1.1047, p=0.00001
Increase in serum C4
coef=0.2990, p=0.00157

Treg phenotypes and T-cell subset/Treg ratios (secondary analysis)

Increase in Tregs
coef=1.749, p=0.0044
Elevated proportions of Tregs with inhibitory function (fTregs)
coef=0.7294, p=0.0178
Change in peripheral helper T cells/fTreg ratio
coef=−4.475, p=0.0319
Change in T helper 17/fTreg ratio
coef=−6.7868, p=0.0327
Variation in TIM-3 expression
coef=0.2422, p=0.039

Original publication

High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosus. Lupus Sci Med. Published 6 October 2023. doi:10.1136/lupus-2023-000976

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.